| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 251 | 2024 |
| Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma RA Noble, N Bell, H Blair, A Sikka, H Thomas, N Phillips, S Nakjang, ... Haematologica 102 (7), 1247, 2017 | 126 | 2017 |
| Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine RE Crossland, J Norden, LA Bibby, J Davis, AM Dickinson Journal of immunological methods 429, 39-49, 2016 | 87 | 2016 |
| Prognostic significance of immunohistochemistry‐based markers and algorithms in immunochemotherapy‐treated diffuse large B cell lymphoma patients RE Culpin, M Sieniawski, B Angus, GK Menon, SJ Proctor, P Milne, ... Histopathology 63 (6), 788-801, 2013 | 60 | 2013 |
| A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines RE Culpin, SJ Proctor, B Angus, S Crosier, JJ Anderson, T Mainou-Fowler International journal of oncology 37 (2), 367-376, 2010 | 54 | 2010 |
| Serum and extracellular vesicle microRNAs miR-423, miR-199, and miR-93* as biomarkers for acute graft-versus-host disease RE Crossland, J Norden, M Kralj Juric, KF Pearce, C Lendrem, LA Bibby, ... Frontiers in immunology 8, 1446, 2017 | 32 | 2017 |
| Expression of serum microRNAs is altered during acute graft-versus-host disease RE Crossland, J Norden, MK Juric, K Green, KF Pearce, C Lendrem, ... Frontiers in Immunology 8, 308, 2017 | 31 | 2017 |
| Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens CD Carey, D Gusenleitner, B Chapuy, AE Kovach, MJ Kluk, HH Sun, ... The Journal of Molecular Diagnostics 17 (1), 19-30, 2015 | 31 | 2015 |
| Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics JJ Anderson, S Fordham, L Overman, H Dignum, K Wood, SJ Proctor, ... International journal of oncology 35 (5), 961-971, 2009 | 30 | 2009 |
| Anti-angiogenic miR-222, miR-195, and miR-21a plasma levels in T1DM are improved by metformin therapy, thus elucidating its cardioprotective effect: The MERIT study FW Ahmed, S Bakhashab, IT Bastaman, RE Crossland, M Glanville, ... International Journal of Molecular Sciences 19 (10), 3242, 2018 | 27 | 2018 |
| Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma AM Newman, M Zaka, P Zhou, AE Blain, A Erhorn, A Barnard, ... Leukemia 36 (3), 781-789, 2022 | 26 | 2022 |
| MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B … RE Culpin, M Sieniawski, SJ Proctor, G Menon, T Mainou-Fowler Journal of clinical pathology 66 (3), 249-252, 2013 | 26 | 2013 |
| Potential novel biomarkers in chronic graft-versus-host disease RE Crossland, F Perutelli, K Bogunia-Kubik, N Mooney, ... Frontiers in Immunology 11, 602547, 2020 | 25 | 2020 |
| Genetic association of hematopoietic stem cell transplantation outcome beyond histocompatibility genes R Gam, P Shah, RE Crossland, J Norden, AM Dickinson, R Dressel Frontiers in immunology 8, 380, 2017 | 24 | 2017 |
| Tissue-specific expression patterns of microRNA during acute graft-versus-host disease in the rat D Jalapothu, M Boieri, RE Crossland, P Shah, IA Butt, J Norden, ... Frontiers in Immunology 7, 361, 2016 | 22 | 2016 |
| Differential MICRORNA expression levels in cutaneous acute graft-versus-host disease S Atarod, J Norden, LA Bibby, A Janin, P Ratajczak, C Lendrem, ... Frontiers in Immunology 9, 1485, 2018 | 19 | 2018 |
| The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of survival following first-line chemotherapy R Mazumdar, P Evans, R Culpin, J Bailey, D Allsup Leukemia research 37 (6), 614-618, 2013 | 16 | 2013 |
| B-cell-based and soluble biomarkers in body liquids for predicting acute/chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation MK Juric, M Shevtsov, P Mozes, J Ogonek, RE Crossland, AM Dickinson, ... Frontiers in immunology 7, 660, 2017 | 14 | 2017 |
| Review of genetic variation as a predictive biomarker for chronic graft-versus-host-disease after allogeneic stem cell transplantation J Partanen, K Hyvärinen, H Bickeböller, K Bogunia-Kubik, RE Crossland, ... Frontiers in Immunology 11, 575492, 2020 | 13 | 2020 |
| Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease RE Crossland, J Norden, S Ghimire, MK Juric, KF Pearce, C Lendrem, ... Frontiers in Immunology 12, 639171, 2021 | 12 | 2021 |
Anne DickinsonProfessor在 ncl.ac.uk 的电子邮件经过验证
